PortfoliosLab logo

Regeneron Pharmaceuticals, Inc.

REGN
Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US75886F1075
CUSIP
75886F107

REGNPrice Chart


Chart placeholderClick Calculate to get results

REGNPerformance

The chart shows the growth of $10,000 invested in Regeneron Pharmaceuticals, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $232,383 for a total return of roughly 2,223.83%. All prices are adjusted for splits and dividends.


REGN (Regeneron Pharmaceuticals, Inc.)
Benchmark (S&P 500)

REGNReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M-11.53%
6M16.71%
YTD18.47%
1Y-0.01%
5Y9.51%
10Y25.19%

REGNMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

REGNSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Regeneron Pharmaceuticals, Inc. Sharpe ratio is -0.02. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


REGN (Regeneron Pharmaceuticals, Inc.)
Benchmark (S&P 500)

REGNDividends


Regeneron Pharmaceuticals, Inc. doesn't pay dividends

REGNDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


REGN (Regeneron Pharmaceuticals, Inc.)
Benchmark (S&P 500)

REGNWorst Drawdowns

The table below shows the maximum drawdowns of the Regeneron Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Regeneron Pharmaceuticals, Inc. is 53.84%, recorded on Sep 27, 2019. It took 168 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-53.84%Aug 6, 20151044Sep 27, 2019168May 29, 20201212
-32.95%Apr 28, 201171Aug 8, 201120Sep 6, 201191
-32.13%Jul 21, 2020156Mar 3, 2021119Aug 20, 2021275
-31.75%Feb 18, 201094Jul 1, 2010114Dec 13, 2010208
-31%Sep 9, 201151Nov 18, 201134Jan 10, 201285
-23.81%May 15, 201327Jun 21, 201358Sep 13, 201385
-20.96%Apr 30, 201243Jun 28, 201239Aug 23, 201282
-20.23%Feb 25, 201487Jun 27, 201433Aug 14, 2014120
-20.19%Sep 2, 202132Oct 18, 2021
-17.29%Oct 2, 201354Dec 17, 201337Feb 11, 201491

REGNVolatility Chart

Current Regeneron Pharmaceuticals, Inc. volatility is 18.97%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


REGN (Regeneron Pharmaceuticals, Inc.)
Benchmark (S&P 500)

Portfolios with Regeneron Pharmaceuticals, Inc.


Loading data...

More Tools for Regeneron Pharmaceuticals, Inc.